Literature DB >> 23989133

Agreement between time-domain and spectral-domain optical coherence tomography in the assessment of macular thickness in patients with idiopathic macular telangiectasia type 2.

Raeba Mathew1, Sobha Sivaprasad, Daniela Florea, Irene Leung, Ferenc Sallo, Traci Clemons, Alan C Bird, Tunde Peto.   

Abstract

PURPOSE: To estimate the conversion factors to transpose macular thickness measurements on time-domain (TD) to various spectral-domain (SD) optical coherence tomography (OCT) machines in patients with macular telangiectasia type 2a (MacTel). PROCEDURES: Macular scans on TD- and SD-OCT were performed on patients at the same visit. The retinal thickness values in various ETDRS subfields and macular volume were compared between different OCT machines.
RESULTS: The macular thickness and volume were significantly greater (p < 0.0001, r = 0.678-0.822) on SD-OCT. The mean differences in macular thickness between TD Stratus and SD-OCT by Spectralis, Cirrus and Topcon were 62, 41 and 20 μm, respectively. The conversion factor of macular thickness from TD-OCT to Spectralis, Cirrus and Topcon were +65, +39 and +25 μm, respectively. CONCLUSION AND MESSAGE: The estimates of conversion of macular thickness from TD- to SD-OCT using simple mean differences between machines and those by linear regression were similar suggesting that the former may be used for the longitudinal follow-up of MacTel patients.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23989133     DOI: 10.1159/000353455

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  3 in total

1.  SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2.

Authors:  Qinqin Zhang; Ruikang K Wang; Chieh-Li Chen; Andrew D Legarreta; Mary K Durbin; Lin An; Utkarsh Sharma; Paul F Stetson; John E Legarreta; Luiz Roisman; Giovanni Gregori; Philip J Rosenfeld
Journal:  Retina       Date:  2015-11       Impact factor: 4.256

2.  Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression.

Authors:  Roberto Bonelli; Brendan R E Ansell; Luca Lotta; Thomas Scerri; Traci E Clemons; Irene Leung; Tunde Peto; Alan C Bird; Ferenc B Sallo; Claudia Langenberg; Melanie Bahlo
Journal:  Genome Med       Date:  2021-03-09       Impact factor: 11.117

3.  Using Patient-Level Data to Develop Meaningful Cross-Trial Comparisons of Visual Impairment in Individuals with Diabetic Macular Edema.

Authors:  Sobha Sivaprasad; Stephane A Regnier; Franck Fajnkuchen; Jonathan Wright; Alan R Berger; Paul Mitchell; Michael Larsen
Journal:  Adv Ther       Date:  2016-03-07       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.